BIOMAT Database Logo BIOMAT Database Logo

[Antiarrhythmic and electrophysiological properties of etmozin and its diethylamine analog]. 1979

V V Lyskovtsev, and Z P Senova, and I A Iuriavichus, and V M Chikharev, and L V Rozenshtraukh

Effects of antiarrhythmic drug etmosin and its diethylamine analogue (etmosin DAA) were compared in dogs with the ventricular rhythm disturbances induced by coronary artery ligation according to Harris' method. As demonstrated, both drugs stopped ventricular rhythm disturbances, but etmosin DAA had a more rapid and prolonged effect. Electrophysiological properties of etmosin and etmosin DAA were studied by the method of potential fixation on trabeculae of frog atria. Both drugs proved to reduce rapid sodium inflow, etmosin DAA acting more intensively and longer. Taking into account the high antiarrhythmic activity of etmosin DAA it is believed that this drug had good prospects for further investigation.

UI MeSH Term Description Entries
D007473 Ion Channels Gated, ion-selective glycoproteins that traverse membranes. The stimulus for ION CHANNEL GATING can be due to a variety of stimuli such as LIGANDS, a TRANSMEMBRANE POTENTIAL DIFFERENCE, mechanical deformation or through INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS. Membrane Channels,Ion Channel,Ionic Channel,Ionic Channels,Membrane Channel,Channel, Ion,Channel, Ionic,Channel, Membrane,Channels, Ion,Channels, Ionic,Channels, Membrane
D008564 Membrane Potentials The voltage differences across a membrane. For cellular membranes they are computed by subtracting the voltage measured outside the membrane from the voltage measured inside the membrane. They result from differences of inside versus outside concentration of potassium, sodium, chloride, and other ions across cells' or ORGANELLES membranes. For excitable cells, the resting membrane potentials range between -30 and -100 millivolts. Physical, chemical, or electrical stimuli can make a membrane potential more negative (hyperpolarization), or less negative (depolarization). Resting Potentials,Transmembrane Potentials,Delta Psi,Resting Membrane Potential,Transmembrane Electrical Potential Difference,Transmembrane Potential Difference,Difference, Transmembrane Potential,Differences, Transmembrane Potential,Membrane Potential,Membrane Potential, Resting,Membrane Potentials, Resting,Potential Difference, Transmembrane,Potential Differences, Transmembrane,Potential, Membrane,Potential, Resting,Potential, Transmembrane,Potentials, Membrane,Potentials, Resting,Potentials, Transmembrane,Resting Membrane Potentials,Resting Potential,Transmembrane Potential,Transmembrane Potential Differences
D009025 Morpholines Tetrahydro-1,4-Oxazines,Tetrahydro 1,4 Oxazines
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D010640 Phenothiazines Compounds containing dibenzo-1,4-thiazine. Some of them are neuroactive.
D011898 Ranidae The family of true frogs of the order Anura. The family occurs worldwide except in Antarctica. Frogs, True,Rana,Frog, True,True Frog,True Frogs
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D004594 Electrophysiology The study of the generation and behavior of electrical charges in living organisms particularly the nervous system and the effects of electricity on living organisms.

Related Publications

V V Lyskovtsev, and Z P Senova, and I A Iuriavichus, and V M Chikharev, and L V Rozenshtraukh
[Effect of the diethylamine analog of etmozin on myocardial function (a clinical and experimental study)].
January 1982, Kardiologiia,
V V Lyskovtsev, and Z P Senova, and I A Iuriavichus, and V M Chikharev, and L V Rozenshtraukh
[Mechanism of the antiarrhythmic action of etmozin].
January 1973, Farmakologiia i toksikologiia,
V V Lyskovtsev, and Z P Senova, and I A Iuriavichus, and V M Chikharev, and L V Rozenshtraukh
[Electrophysiological evaluation of the anti-arrhythmia activity of ethmozin and its diethylamine analog in patients with Wolff-Parkinson-White syndrome].
January 1982, Terapevticheskii arkhiv,
V V Lyskovtsev, and Z P Senova, and I A Iuriavichus, and V M Chikharev, and L V Rozenshtraukh
[Effect of the diethylamine analog of etmozin and cesium chloride on the idioventricular rhythm in dogs in the late stages of experimental myocardial infarct].
October 1981, Biulleten' eksperimental'noi biologii i meditsiny,
V V Lyskovtsev, and Z P Senova, and I A Iuriavichus, and V M Chikharev, and L V Rozenshtraukh
[Adrenaline-induced autorhythmic activity in the isolated atrial myocardium of mitral stenosis patients and its suppression by etmozin and ethacizin (the diethylamino analog of etmozin)].
October 1984, Biulleten' eksperimental'noi biologii i meditsiny,
V V Lyskovtsev, and Z P Senova, and I A Iuriavichus, and V M Chikharev, and L V Rozenshtraukh
Electrophysiological and antiarrhythmic properties of propafenon in isolated cardiac preparations.
January 1981, Journal of cardiovascular pharmacology,
V V Lyskovtsev, and Z P Senova, and I A Iuriavichus, and V M Chikharev, and L V Rozenshtraukh
[Effect of etmozin and ethacizin (diethylamino analog of etmozin) on local microcardiac blood flow and the fibrillation threshold of the heart].
May 1984, Kardiologiia,
V V Lyskovtsev, and Z P Senova, and I A Iuriavichus, and V M Chikharev, and L V Rozenshtraukh
Electrophysiological and antiarrhythmic properties of potassium canrenoate during myocardial ischemia-reperfusion.
May 2015, Journal of cardiovascular pharmacology and therapeutics,
V V Lyskovtsev, and Z P Senova, and I A Iuriavichus, and V M Chikharev, and L V Rozenshtraukh
The antiarrhythmic properties of ICI 46037, a quaternary analog of propranolol.
July 1968, The Journal of pharmacology and experimental therapeutics,
V V Lyskovtsev, and Z P Senova, and I A Iuriavichus, and V M Chikharev, and L V Rozenshtraukh
Lack of correlation between the antiarrhythmic effect of L-propionylcarnitine on reoxygenation-induced arrhythmias and its electrophysiological properties.
January 1991, British journal of pharmacology,
Copied contents to your clipboard!